Viswanathan Shankar

9PUBLICATIONS
30CO-AUTHORS
Molecular targetsInnate immunitySocial epidemiologyRadiation therapyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 12, 2026
Participation of Patients With Gynecologic Cancer in Phase I Clinical Trials: Experience From Two National Cancer Institute-Designated Comprehensive Cancer Centers.

|Jul 30, 2025
Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection.

Fanua Wiek, Viswanathan Shankar, Ana Gradissimo

|Jul 03, 2024
Association Between Social Determinants of Health and Cancer Treatment Delay in an Urban Population.

Faye G Zhang, Risha Sheni, Chenxin Zhang

|Nov 21, 2023
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).

Nitin Ohri, Shruti Jolly, Benjamin T Cooper

|Jul 29, 2023
TRiCit: A High-Throughput Approach to Detect Trichomonas vaginalis from ITS1 Amplicon Sequencing.

Mykhaylo Usyk, Nicolas F Schlecht, Shankar Viswanathan

|Mar 31, 2023
Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.

Risha Sheni, Jiyue Qin, Shankar Viswanathan

Pageof 2

Frequent Collaborators

2 joint publications

Risha Sheni

1 joint publications

Melvin Joy

1 joint publications

Thenmozhi Mani

1 joint publications

L Jeyaseelan